Study Assessing Activity of Molecularly Matched Targeted Therapies in Select Tumor Types Based on Genomic Alterations

Clinical trial NCT02795156 · COMPLETED

Trial details

NCT number: NCT02795156
Sponsor: SCRI Development Innovations, LLC
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Non-small Cell Lung Carcinoma Urothelial Carcinoma Gastrointestinal Carcinoma, Non-colon Upper Aerodigestive Tract Carcinoma

Start date: 2016-09-28
Primary completion: 2022-08-17
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.